Variable | N | % |
---|---|---|
Demographic and clinical characteristics | Â | Â |
Male | 12 | 85.7 |
White/Caucasian | 13 | 92.8 |
Australian born | 13 | 92.8 |
ATSI descent | 0 | - |
Unemployed | 13 | 92.8 |
Primary diagnosis | Â | Â |
Schizophrenia | 1 | 7.1 |
Paranoid schizophrenia | 7 | 50.0 |
Schizoaffective disorder | 4 | 28.6 |
Bipolar affective disorder | 2 | 14.3 |
Prescribed medications | Â | Â |
Clozapine (mean dosage; mg)a | 8 (403.1) | 57.1 |
Polypharmacy (≥ 5)a | 13 | 92.8 |
High polypharmacy (≥ 9)a | 11 | 78.6 |
Physical characteristics | Â | Â |
Current smoking | 4 | 28.6 |
Metabolic health | Â | Â |
Normal weightb | 1 | 5.9 |
Pre-obesity (overweight)b | 5 | 29.4 |
Obesityb | 11 | 64.7 |
 | M | SD |
BMI | 34.6 | 8.4 |
Waist circumference (cm) | 120.4 | 15.0 |
Frailty Index at screening | 0.35 | 0.08 |
Clinical assessments | Â | Â |
Psychosis symptoms (PANSS total scale) | 66.6 | 13.1 |
Physical component (SF-36) | 55.6 | 26.1 |
Mental component (SF-36) | 62.4 | 20.4 |
Global functioning (GAF total score) | 47.8 | 6.1 |
Quality of life (AQOL-8D total score) | 64.8 | 14.8 |
Physical activity (min; SIMPAQ)c | 184.6 | 217.9 |
Sedentary time (min; SIMPAQ) | 588.6 | 256.3 |
Fruit & vegetable intake (portions; FACET) | 4.4 | 2.4 |
Sleep (PSQI global score) | 6.8 | 4.0 |